China's top three leading amino acid producers stocks?
Leading Amino Acid stocks are stocks that have a leading position in the amino acid industry. These companies specialize in the research, development, production, and marketing of amino acids, which provide key ingredients for the food, pharmaceutical, and nutraceutical industries. The following is a list of the top three leading amino acid producer stocks in China, which is of great benefit to all of you, so let's take a look together.
China's top three amino acid producers
Meihua Bio (6008?): a leading amino acid stock. One of the world's leading monosodium glutamate (MSG), ranked second in China, the largest amino acid producer in China; sales of food taste shape optimization products (including monosodium glutamate (MSG) and disodium monosodium glutamate (DSG)) 6.11 billion yuan in 19 years, the main accounted for 42%.
The company is a leading domestic and international first-class biotechnology company focusing on the use of biological fermentation technology for the research and development, production and sales of animal nutritional amino acids, human medical amino acids, food taste shape optimization products. The company has a complete industrial chain layout in the field of corn deep processing and has taken the lead in the industry to achieve a leading scale advantage, the company's flavor agent equivalent of nearly one million tons, animal nutrition amino acid production capacity of more than one million tons, other types of high-grade medical health care amino acid production capacity of tens of thousands of tons, is the world's largest amino acid production capacity of the largest one of the enterprises. At present, Tongliao, Xinjiang, Baicheng three major production bases are equipped with a complete integrated production line for comprehensive utilization of resources.
Dec. 30 news, plum blossom biological latest offer 7.6 yuan, 3 days the share price rose 2.76%; this year, up 16.05%, the price-earnings ratio of 23.75.
Jialong shares (002495): the last 7 trading days, jialong shares fell 18.49%, the highest price of 2.69 yuan, the total market value fell by 458 million yuan,. Down 18.49%.
HISCO (002653): shares are up 2.57% in the last 7 days and 11.26% in 2021.
What are the leading stocks in the biomedical sector
The biomedical sector is one of the hot industries in the current capital market, and there are a number of listed companies with strong competitiveness and performance.
The stocks as the leading ones mainly include: United Amino Acids, Hengrui Medicine, WuXi Biotechnology, Myriad Medical and so on. These companies in the field of biopharmaceuticals, medical diagnostics, health services and other areas of high technology content and innovation, market prospects, investors can pay attention to these companies with leading potential, according to the actual situation of prudent investment.
What are the leading domestic and foreign enterprises in the amino acid industry
Japan's Ajinomoto (Ajinomoto), Germany's Deguasa, Taiwan's Aidan International, South Korea's CJ, the U.S. ADM and Japan's KyowaHakko are the world's leading amino acid producers; amino acid industry. leading domestic enterprises are Meihua Group and Litai Pharmaceuticals.
Which companies in Shandong have amino acid ammonium sulfate
Shandong Juweitai Bio-technology Co. Shandong Juweitai Bio-technology Co., Ltd. is an ammonium sulfate manufacturer, mainly engaged in fumaric acid, L-aspartic acid . Ammonium sulfate, L-alanine and other products, with production process equipment and testing technology, the use of fine chemical technology, the production of amino acid series.
What are the leading amino acid stocks
1, Fengyuan Pharmaceuticals: in the third quarter of 2022, the company realized total revenue of 968 million, gross margin of 27.98%, earnings per share of 0.12 yuan.
Subsidiary Likang Pharmaceutical production capacity of 5,000 tons, the company's main business mainly consists of preparations, APIs, health care and commercial logistics four major segments: preparations segment in the chemical preparation of the main at the same time, and actively carry out cooperation with various key scientific research institutes and universities, the development of the new generation of bio-innovation of medicines, and actively to the transformation and development of biological preparations. In terms of APIs, through the upgrading of production equipment and high-tech investment, the company has increased the market share of paracetamol, cefpirome, ceftriaxone, cefminox and DC series APIs, and has a number of API reserve projects, aiming to become an advanced API production base in China. Holding subsidiary Likang Pharmaceutical.
In the last seven trading days, Fengyuan Pharmaceuticals rose 11.16%, the highest price of 14.16 yuan, the total market value rose 608 million yuan, up 27.26% in 2022.
2, Renhe Pharmaceuticals: 2022 Q3 quarterly report shows that Renhe Pharmaceuticals Inc. achieved total revenue of $1.285 billion, gross margin of 34.93%, earnings per share of $0.11.
In the last 7 days Renhe Pharmaceuticals shares rose 14.46%, 2022 shares fell -13.02%, the highest price of $8.49, the market capitalization of 11.717 billion.
3, CGC: In the third quarter of 2022, the company realized total revenue of $525 million, gross margin of 62.62%, and earnings per share of $0.01.
In the last 7 trading days, Zhongguancun fell 1.01%, the highest price of $6.94, the total market capitalization fell 52.7189 million yuan, down 1.01%.